| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Sep―01 |
ALK-POSITIVE ALCL IN CHILDREN AND ADOLESCENTS: DECLINE IN INCIDENCE DURING THE COVID-19 PANDEMIC |
Fabian Knörr, Jan Förster, Christine Damm-Welk, Birgit Burkhardt, Willi Wößmann |
| 2 |
[GO] |
2024―Nov―08 |
COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: the UK experience. |
Giovanna Lucchini, Elena Cozma, Aimee Jackson, Kimberly Gilmour, Rachel Protheroe, Keith Wilson, et al. (+18) Karl Peggs, Victoria Potter, Anne Parker, Andy Peniket, Eleni Tholouli, Robert Wynn, Emma Nicholson, Charles Craddock, David I. Marks, Christopher Parrish, Shankara Paneesha, Oana Mirci-Danicar, Alexander M Martin, Graham McIlroy, Rebecca Bishop, Rebecca Collings, Ellie Williams, Persis J. Amrolia |
| 3 |
[GO] |
2023―Jun―22 |
mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect |
Nil Albiol, Elionor Lynton-Pons, Olga Aso, Esther Moga, Silvia Vidal, Lucía Gómez-Pérez, et al. (+10) Jose Alejandre Santiago, Mercè Triquell, Nerea Roch, Elisabeth Lázaro, Iria González, Joaquín López-Contreras, Albert Esquirol, Jorge Sierra, Rodrigo Martino, Irene García-Cadenas |
| 4 |
[GO] |
2023―Mai―29 |
Humoral and Cellular Responses after Third Dose of SARS-CoV-2 Vaccine in Myeloproliferative Neoplasms Patients on Ruxolitinib Therapy |
A. Atanasio, A. Vanni, L. Maggi, S. Pilerci, A. Mazzoni, M. Capone, et al. (+11) F. Crupi, P. Cicogna, V. Boldrini, S. Tekle, M.G. Colao, M. Borella, C. Paoli, G.M. Rossolini, A.M. Vannucchi, F. Annunziato, P. Guglielmelli |
| 5 |
[GO] |
2023―Mai―17 |
Specific Immune Response to mRNA Vaccines Against COVID-19 in Patients Receiving Allogeneic Stem Cell Transplantation for Myeloid Malignancy Was Altered by Immunosuppressive Therapy |
Jana Macková, Petr Hainz, Jitka Kryštofová, Kateřina Roubalová, Markéta Šťastná-Marková, Šárka Vaníková, et al. (+3) Jan Musil, Jan Vydra, Šárka Němečková |
| 6 |
[GO] |
2022―Okt―20 |
TREATING LYMPHOMA IN THE PANDEMIC ERA: WHAT WE LEARNED FROM OUR EXPERIENCE AT FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI |
G. Gattuso, V. Biassoni, M. Podda, C. Meazza, S. Chiaravalli, O. Nigro, et al. (+8) G. Sironi, V. Livellara, N. Puma, L. Bergamaschi, M. Terenziani, F. Spreafico, M. Massimino, E. Schiavello |
| 7 |
[GO] |
2022―Jun―25 |
2022 update on the clinical outcome of coronavirus disease 2019 in haemato-oncology patients |
Susie Bradwell, Luke Hone, Kirstie Thorneycroft, Jonathan Lambourne, James A. Aries, Jeffrey K. Davies, et al. (+2) Teresa Cutino-Moguel, John C. Riches |
| 8 |
[GO] |
2022―Jun―20 |
Characteristics and clinical outcomes of SARS-CoV-2 infection in adult patients with acute leukemia in France |
Pierre-Yves Dumas, Sarah Bertoli, Caroline Bonmati, Martin Carre, Juliette Lambert, Mario Ojeda-Uribe, et al. (+18) Sylvain Chantepie, Franciane Paul, Eric Jourdan, Stéphanie Haiat, Emmanuelle Tavernier, Pierre Peterlin, Jean-Pierre Marolleau, Kamel Laribi, Corentin Orvain, Quentin Cabrera, Pascal Turlure, Stéphane Girault, Marie Balsat, Marc Bernard, Marie-Christine Bene, Arnaud Pigneux, Hervé Dombret, Christian Récher |
| 9 |
[GO] |
2022―Mrz―04 |
Longer-term response to SARS-CoV-2 vaccine in MPN patients: role of ruxolitinib and disease severity. |
Giuseppe Auteri, Daniela Bartoletti, Christian Di Pietro, Emanuele Sutto, Camilla Mazzoni, Andrea Davide Romagnoli, et al. (+4) Nicola Vianelli, Tiziana Lazzarotto, Michele Cavo, Francesca Palandri |
| 10 |
[GO] |
2021―Apr―24 |
High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies |
Alex Niu, Bo Ning, Francisco Socola, Hana Safah, Tim Reynolds, Moayed Ibrahim, et al. (+6) Firas Safa, Tina Alfonso, Alfred Luk, David M. Mushatt, Tony Hu, Nakhle S. Saba |
| 11 |
[GO] |
2021―Apr―24 |
Personalized at-home autologous hematopoietic stem cell transplantation during the SARS-CoV-2 outbreak |
Alexandra Martínez-Roca, Luis Gerardo Rodríguez-Lobato, Nuria Ballestar Dot, Cristina Gallego Miralles, Francesc Fernández-Avilés |
| 12 |
[GO] |
2021―Jan―27 |
The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: Single-centre comparative study between 2019 and 2020 cohorts in Madrid |
Fernando Martín-Moro, Claudia Núnez-Torrón, Lucía Pérez-Lamas, Carlos Jiménez-Chillón, Juan Marquet-Palomanes, Javier López-Jiménez, Pilar Herrera-Puente |
| 13 |
[GO] |
2021―Jan―20 |
Reinfection Versus Failure of Viral Clearance in a COVID-19 Patient with Hematologic Malignancy |
Moayed Ibrahim, Andrew Vegel, Alex Niu, Ketaki Panse, Rebecca Chen, Hana Safah, et al. (+3) Francisco Socola, Alfred Luk, Nakhle S. Saba |
| 14 |
[GO] |
2020―Nov―13 |
Lymphocyte-Depleting Chemotherapy for Aggressive Hematologic Malignancies in Two Patients with Positive SARS-CoV-2 PCR |
Ari Pelcovits, Aakriti Pandita, Dimitrios Farmakiotis, Pamela Egan |
| 15 |
[GO] |
2020―Jun―30 |
Immunosuppression in hematological cancer patients with Covid-19 - uncomplicated infections but delayed viral clearance? |
Karen Boyd, Benjamin Parcell, Sudhir Tauro |
| 16 |
[GO] |
2020―Apr―30 |
Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia |
S. Paneesha, G. Pratt, H. Parry, P. Moss |
| 17 |
[GO] |
2020―Mrz―26 |
Acute Leukemia in the Time of COVID-19 |
Mathilde Gavillet, Jeanette Carr Klappert, Olivier Spertini, Sabine Blum |
|
